Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A type of therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases. Some types of immunotherapy only target certain cells of the immune system. Others affect the immune system in a general way.
This report elaborates on the current development of the Immunotherapy Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
F Hoffmann-La Roche AG
Merck
Bayer AG
Novartis
Eli Lilly and Company
Amgen
Janssen Global Services, LLC
Bristol-Myers Squibb
Pfizer
By Type:
Other Drugs
Adult Vaccines
Checkpoint Inhibitors
Monoclonal Antibodies
Interleukins
Interferons Alpha & Beta
By Application:
Other Therapy Area
Cancer
Infectious Diseases
Autoimmune & Inflammatory Diseases
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Immunotherapy Drugs Market Overview 2018-2029
-
1.1 China Immunotherapy Drugs Industry Development Overview
-
1.2 China Immunotherapy Drugs Industry Development History
-
1.3 China Immunotherapy Drugs Industry Market Size (2018-2029)
-
1.4 China Immunotherapy Drugs Market Analysis by Type from Production Side
-
1.4.1 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Other Drugs (2018-2029)
-
1.4.2 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Adult Vaccines (2018-2029)
-
1.4.3 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Checkpoint Inhibitors (2018-2029)
-
1.4.4 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.5 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)
-
1.4.6 China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Interferons Alpha & Beta (2018-2029)
-
1.5 China Immunotherapy Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Other Therapy Area (2018-2029)
-
1.5.2 China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.5.3 China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
1.5.4 China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Autoimmune & Inflammatory Diseases (2018-2029)
-
1.6 China Immunotherapy Drugs Market Analysis by Region
-
1.6.1 North China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Immunotherapy Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Immunotherapy Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Immunotherapy Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Immunotherapy Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Immunotherapy Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Immunotherapy Drugs Industry Development
Chapter 3 Immunotherapy DrugsIndustry Chain Analysis
-
3.1 Immunotherapy Drugs Industry Chain
-
3.2 Immunotherapy Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Immunotherapy Drugs Market
-
3.3 Immunotherapy Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Immunotherapy Drugs Market
Chapter 4 China Immunotherapy Drugs Market, by Type
-
4.1 China Immunotherapy Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Immunotherapy Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Immunotherapy Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Immunotherapy Drugs Production Volume and Growth Rate of Other Drugs
-
4.5.2 China Immunotherapy Drugs Production Volume and Growth Rate of Adult Vaccines
-
4.5.3 China Immunotherapy Drugs Production Volume and Growth Rate of Checkpoint Inhibitors
-
4.5.4 China Immunotherapy Drugs Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.5 China Immunotherapy Drugs Production Volume and Growth Rate of Interleukins
-
4.5.6 China Immunotherapy Drugs Production Volume and Growth Rate of Interferons Alpha & Beta
Chapter 5 China Immunotherapy Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Immunotherapy Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Immunotherapy Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Immunotherapy Drugs Market Size and Growth Rate of Other Therapy Area
-
5.5.2 China Immunotherapy Drugs Market Size and Growth Rate of Cancer
-
5.5.3 China Immunotherapy Drugs Market Size and Growth Rate of Infectious Diseases
-
5.5.4 China Immunotherapy Drugs Market Size and Growth Rate of Autoimmune & Inflammatory Diseases
Chapter 6 China Immunotherapy Drugs Market, by Region
-
6.1 China Immunotherapy Drugs Production Volume and Production Value, by Region
-
6.2 China Immunotherapy Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Immunotherapy Drugs Market Analysis
-
7.1 North China Immunotherapy Drugs Market, by Type
-
7.2 North China Immunotherapy Drugs Market, by Application
Chapter 8 Central China Immunotherapy Drugs Market Analysis
-
8.1 Central China Immunotherapy Drugs Market, by Type
-
8.2 Central China Immunotherapy Drugs Market, by Application
Chapter 9 South China Immunotherapy Drugs Market Analysis
-
9.1 South China Immunotherapy Drugs Market, by Type
-
9.2 South China Immunotherapy Drugs Market, by Application
Chapter 10 East China Immunotherapy Drugs Market Analysis
-
10.1 East China Immunotherapy Drugs Market, by Type
-
10.2 East China Immunotherapy Drugs Market, by Application
Chapter 11 Northeast China Immunotherapy Drugs Market Analysis
-
11.1 Northeast China Immunotherapy Drugs Market, by Type
-
11.2 Northeast China Immunotherapy Drugs Market, by Application
Chapter 12 Southwest China Immunotherapy Drugs Market Analysis
-
12.1 Southwest China Immunotherapy Drugs Market, by Type
-
12.2 Southwest China Immunotherapy Drugs Market, by Application
Chapter 13 Northwest China Immunotherapy Drugs Market Analysis
-
13.1 Northwest China Immunotherapy Drugs Market, by Type
-
13.2 Northwest China Immunotherapy Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 F Hoffmann-La Roche AG
-
14.1.1 F Hoffmann-La Roche AG Company Profile
-
14.1.2 F Hoffmann-La Roche AG Immunotherapy Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck
-
14.2.1 Merck Company Profile
-
14.2.2 Merck Immunotherapy Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bayer AG
-
14.3.1 Bayer AG Company Profile
-
14.3.2 Bayer AG Immunotherapy Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Novartis
-
14.4.1 Novartis Company Profile
-
14.4.2 Novartis Immunotherapy Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Eli Lilly and Company
-
14.5.1 Eli Lilly and Company Company Profile
-
14.5.2 Eli Lilly and Company Immunotherapy Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Amgen
-
14.6.1 Amgen Company Profile
-
14.6.2 Amgen Immunotherapy Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Janssen Global Services, LLC
-
14.7.1 Janssen Global Services, LLC Company Profile
-
14.7.2 Janssen Global Services, LLC Immunotherapy Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Bristol-Myers Squibb
-
14.8.1 Bristol-Myers Squibb Company Profile
-
14.8.2 Bristol-Myers Squibb Immunotherapy Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Pfizer
-
14.9.1 Pfizer Company Profile
-
14.9.2 Pfizer Immunotherapy Drugs Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Immunotherapy Drugs Industry Research Conclusions
-
15.2 Immunotherapy Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Immunotherapy Drugs Industry Market Size (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Other Drugs (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Adult Vaccines (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Checkpoint Inhibitors (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)
-
Figure China Immunotherapy Drugs Production Volume, Production Value and Growth Rate of Interferons Alpha & Beta (2018-2029)
-
Figure China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Other Therapy Area (2018-2029)
-
Figure China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)
-
Figure China Immunotherapy Drugs Sales Volume, Sales Value and Growth Rate of Autoimmune & Inflammatory Diseases (2018-2029)
-
Figure North China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Immunotherapy Drugs Market Size and Growth Rate from 2018-2029
-
Figure Immunotherapy Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Immunotherapy Drugs Market Share by Type in 2018
-
Figure China Immunotherapy Drugs Market Share by Type in 2023
-
Figure China Immunotherapy Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Other Drugs (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Adult Vaccines (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Checkpoint Inhibitors (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Interleukins (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume and Growth Rate of Interferons Alpha & Beta (2018-2023)
-
Figure China Immunotherapy Drugs Market Share by Application in 2018
-
Figure China Immunotherapy Drugs Market Share by Application in 2023
-
Figure China Immunotherapy Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Immunotherapy Drugs Market Size and Growth Rate of Other Therapy Area (2018-2023)
-
Figure China Immunotherapy Drugs Market Size and Growth Rate of Cancer (2018-2023)
-
Figure China Immunotherapy Drugs Market Size and Growth Rate of Infectious Diseases (2018-2023)
-
Figure China Immunotherapy Drugs Market Size and Growth Rate of Autoimmune & Inflammatory Diseases (2018-2023)
-
Table China Immunotherapy Drugs Production Volume by Region (2018-2023)
-
Table China Immunotherapy Drugs Production Volume Share by Region (2018-2023)
-
Figure China Immunotherapy Drugs Production Volume Share by Region (2018-2023)
-
Table China Immunotherapy Drugs Production Value by Region (2018-2023)
-
Table China Immunotherapy Drugs Production Value Share by Region (2018-2023)
-
Figure China Immunotherapy Drugs Production Value Share by Region (2018-2023)
-
Table China Immunotherapy Drugs Sales Volume by Region (2018-2023)
-
Table China Immunotherapy Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Immunotherapy Drugs Sales Volume Share by Region (2018-2023)
-
Table China Immunotherapy Drugs Sales Value by Region (2018-2023)
-
Table China Immunotherapy Drugs Sales Value Share by Region (2018-2023)
-
Figure China Immunotherapy Drugs Sales Value Share by Region (2018-2023)
-
Table North China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table North China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table North China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table North China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table Central China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table Central China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table South China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table South China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table South China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table East China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table East China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table East China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Immunotherapy Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Immunotherapy Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Immunotherapy Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Immunotherapy Drugs Sales Volume Share by Application (2018-2023)
-
Table F Hoffmann-La Roche AG Company Profile
-
Table F Hoffmann-La Roche AG Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Company Company Profile
-
Table Eli Lilly and Company Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Janssen Global Services, LLC Company Profile
-
Table Janssen Global Services, LLC Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Immunotherapy Drugs Revenue, Price and Gross (2018-2023)
-
